Literature DB >> 20151723

Measuring quality of life for certain events versus pre-specified points in time.

Mattias Neyt1.   

Abstract

Mesh：

Year:  2010        PMID： 20151723     DOI： 10.2165/11530990-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  5 in total

Review 1.  A comparative review of generic quality-of-life instruments.

Authors:  S J Coons; S Rao; D L Keininger; R D Hays
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

2.  Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility.

Authors:  Andrea Manca; Neil Hawkins; Mark J Sculpher
Journal:  Health Econ       Date:  2005-05       Impact factor: 3.046

3.  Cost effectiveness of drug-eluting stents in Belgian practice: healthcare payer perspective.

Authors:  Mattias Neyt; Chris De Laet; Annemieke De Ridder; Hans Van Brabandt
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 4.  Valuing health States for use in cost-effectiveness analysis.

Authors:  John Brazier
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

5.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.

Authors:  P W Serruys; F Unger; J E Sousa; A Jatene; H J Bonnier; J P Schönberger; N Buller; R Bonser; M J van den Brand; L A van Herwerden; M A Morel; B A van Hout
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245
  5 in total
  1 in total

1.  Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditions.

Authors:  Mattias Neyt; Stephan Devriese; Nancy Thiry; Ann Van den Bruel
Journal:  BMC Pulm Med       Date:  2010-09-15       Impact factor: 3.317
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.